Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33)

קרןNational Cancer Institute/NIH
סוגResearch Grants
תאריך אחרון01/09/2023
פקולטהEngineering, Exact Sciences, Life Sciences, Medicine

This grant solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies that improve the quality of the samples used for cancer research or clinical care. This includes new capabilities to address issues related to pre-analytical degradation of targeted analytes during the collection, processing, handling, and/or storage of cancer-relevant biospecimens.

 This grant solicits R33 applications where major feasibility gaps for the technology or methodology have been overcome, as demonstrated with supportive preliminary data, but still require further development and rigorous validation to encourage adoption by the research community. 


Funding: $300,000 per year 

Duration: 3 years



Research Authority due date: 10 days prior to submission 

LOI (encouraged) due date: 1.2.23, 1.8.23

Full proposal due date: 1.3.23, 1.9.23



קבצים מצורפים
עדכון אחרוןעדכון אחרון: 04/12/2022
אוניברסיטת תל אביב עושה כל מאמץ לכבד זכויות יוצרים. אם בבעלותך זכויות יוצרים בתכנים שנמצאים פה ו/או השימוש
שנעשה בתכנים אלה לדעתך מפר זכויות, נא לפנות בהקדם לכתובת שכאן >>